xtandi
astellas pharma europe b.v. - enzalutamida - neoplasmas prostáticos - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
enzalutamida 40 mg
lotus pharmaceuticals co. ltd - enzalutamida - cápsula blanda - 40 mg
enzalutamida cápsulas blandas 40 mg
novartis chile s.a. - enzalutamida - sin formulas
enzalutamida cápsulas 40 mg
remus pharmaceuticals pvt. ltd. india - enzalutamida 40 mg - capsulas - cada cápsula contiene: enzalutamida 40 mg
enzalutamida 40 mg capsula blanda
laboratorios stein s.a. costa rica - enzalutamida 40 mg - capsula blanda - cada cápsula blanda contiene: enzalutamida * 40,000 mg
enzalutamida 40 mg capsulas
psicofarma s.a. [ec] ecuador - enzalutamida 40 mg - capsulas de gelatina dura - cada cápsula de gelatina dura contiene: enzalutamida* 40.00 mg
enzavitae cápsulas blandas 40 mg (enzalutamida)
galenicum health chile s.p.a. - enzalutamida - sin formulas
xtandi cápsulas blandas 40 mg (enzalutamida)
tecnofarma s.a. - enzalutamida - sin formulas
xalut cápsulas blandas 40 mg (enzalutamida)
megalabs chile s.a. - enzalutamida - sin formulas
tuprocyde cápsulas blandas 40 mg (enzalutamida)
dr. reddy's laboratories chile s.p.a. - enzalutamida - sin formulas